| Style | Citing Format |
|---|---|
| MLA | Jiao X, et al.. "Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application." Current Molecular Pharmacology, vol. 9, no. , 2016, pp. -. |
| APA | Jiao X, Ashtari N, Balaei MR, Chen QM, Badbezanchi I, Shojaei S, Marzban A, Mirzaei N, Chung S, Guan T, Li J, Vriend J, Mehr SE, Kong J, Marzban H (2016). Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application. Current Molecular Pharmacology, 9(), -. |
| Chicago | Jiao X, Ashtari N, Balaei MR, Chen QM, Badbezanchi I, Shojaei S, Marzban A, et al.. "Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application." Current Molecular Pharmacology 9, no. (2016): -. |
| Harvard | Jiao X et al. (2016) 'Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application', Current Molecular Pharmacology, 9(), pp. -. |
| Vancouver | Jiao X, Ashtari N, Balaei MR, Chen QM, Badbezanchi I, Shojaei S, et al.. Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application. Current Molecular Pharmacology. 2016;9():-. |
| BibTex | @article{ author = {Jiao X and Ashtari N and Balaei MR and Chen QM and Badbezanchi I and Shojaei S and Marzban A and Mirzaei N and Chung S and Guan T and Li J and Vriend J and Mehr SE and Kong J and Marzban H}, title = {Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application}, journal = {Current Molecular Pharmacology}, volume = {9}, number = {}, pages = {-}, year = {2016} } |
| RIS | TY - JOUR AU - Jiao X AU - Ashtari N AU - Balaei MR AU - Chen QM AU - Badbezanchi I AU - Shojaei S AU - Marzban A AU - Mirzaei N AU - Chung S AU - Guan T AU - Li J AU - Vriend J AU - Mehr SE AU - Kong J AU - Marzban H TI - Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application JO - Current Molecular Pharmacology VL - 9 IS - SP - EP - PY - 2016 ER - |